|
ZNF652 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.53619347745371E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.98980848359543E-12 |
| Normal-vs-Stage2 |
2.294200E-02 |
| Normal-vs-Stage3 |
1.59180446601681E-11 |
| Normal-vs-Stage4 |
1.63313806922361E-12 |
| Stage1-vs-Stage2 |
6.516400E-03 |
| Stage1-vs-Stage3 |
3.551800E-01 |
| Stage1-vs-Stage4 |
3.223900E-03 |
| Stage2-vs-Stage3 |
2.375300E-03 |
| Stage2-vs-Stage4 |
4.44099999999947E-05 |
| Stage3-vs-Stage4 |
8.685700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.41788836017076E-14 |
| Normal-vs-AfricanAmerican |
5.7332000000021E-05 |
| Normal-vs-Asian |
3.16959791746285E-11 |
| Caucasian-vs-AfricanAmerican |
5.492600E-01 |
| Caucasian-vs-Asian |
9.178600E-01 |
| AfricanAmerican-vs-Asian |
6.297200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.83419999480961E-08 |
| Normal-vs-Female |
1.71884728672467E-12 |
| Male-vs-Female |
1.266810E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.97930560830173E-12 |
| Normal-vs-Age(41-60Yrs) |
3.15869552736103E-11 |
| Normal-vs-Age(61-80Yrs) |
5.06559999946532E-07 |
| Normal-vs-Age(81-100Yrs) |
1.404260E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.793200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.554000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.401000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.364200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.853600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.029800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.67869999999826E-05 |
| Classical-VS-Follicular |
3.755000E-04 |
| Classical-VS-Other |
4.723400E-01 |
| Classical-VS-Normal |
1.63036251166204E-12 |
| Tall-VS-Follicular |
4.96289997986565E-09 |
| Tall-VS-Other |
1.469420E-01 |
| Tall-VS-Normal |
1.62470037423645E-12 |
| Follicular-VS-Other |
5.421200E-01 |
| Follicular-VS-Normal |
2.484600E-03 |
| Other-VS-Normal |
2.263800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.10070000283835E-08 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.16439999975348E-07 |
|
|
